Title

Cell-based therapies for disorders of the CNS

Document Type

Journal Article

Publisher

Informa UK Ltd

Faculty

Computing, Health and Science

School

School of Exercise, Biomedical and Health Science

RAS ID

10062

Comments

Originally published as: Lazic, S. E., & Barker, R. A. (2005). Cell-based therapies for disorders of the CNS. Expert Opinion on Therapeutic Patents, 15(10), 1361-1376. Original article available here

Abstract

There are few effective pharmacological-based treatments for acute neurological trauma or chronic neurodegenerative diseases. This has created a demand for innovative therapeutic approaches including gene therapy, deep brain stimulation and cell-based therapies. This review, briefly updates the progress made in recent clinical trials of neurotransplantation in Parkinson's and Huntington's disease, discusses challenges that still have to be overcome, and reviews the progress in meeting these challenges. The main focus of this review, however, will be on recent advances in using endogenous neural precursor cells (NPCs) to promote brain repair. The physiological role of NPCs, their response to various types of injury and other endogenous and exogenous factors will be discussed. Finally, their therapeutic potential and relevance to human disease will be considered.

DOI

10.1517/13543776.15.10.1361

 
COinS
 

Link to publisher version (DOI)

10.1517/13543776.15.10.1361